News from the world
15
May
European Commission outlines plans to mobilize EMA to diversify supply chains
he European Commission has adopted a Global Health Resilience Initiative that gives EMA a role in diversifying global supply chains. Supply chain diversification is one of nine flagship initiatives proposed in the document. Believing that diversified and well-integrated global supply chains help build resilience, the Commission plans to work with global partners to address concentrations of production capabilities responsible for systemic risks. As part of the efforts, the Commission will mobilize EMA and the network of EU national regulatory authorities to support collaborative regulatory pathways. The goal is to support the development and manufacturing of key health products based on mutual interest. The Commission also plans to work with partner countries on regulatory aspects of health science, genome, and biodata repositories. [European Commission]
17
Jul
Inside Pharma’s Push for More Resilient Supply Chains
Industry leaders from Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing,...
17
Jul
US FDA CDER plans new guidance on AI, electronic safety report submissions, and more
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has...
16
Jul
EU DG SANTE and EMA sign Working Arrangement with New Zealand Ministry of Health
DG SANTE and the European Medicines Agency (EMA) have signed a Working Arrangement with New Zealand Ministry...
15
Jul
Riforma farmaceutica. Via libera della Commissione Sanità del Senato
Le poche modifiche approvate non cambiano l'impianto della riforma. L’articolo 3 a...
latest news
15 May
US FDA official details top observations from QMSR inspections
15 May
European Commission outlines plans to mobilize EMA to diversify supply chains
13 May
Deal on tackling EU shortages of essential medicines
12 May
Chimica: Bruxelles non rivedra' le norme REACH
08 May
Farmaceutica, Gemmato: 'per Testo unico deadline entro dicembre'
08 May
Min. Salute Gemmato: “Testo unico farmaceutico entro dicembre 2026”
08 May
Precursori droghe: controllo esteso a 9 nuove sostanze dal 18 settembre 2026
08 May
US FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight